Original Query: ALL
Previous Study | Return to List | Next Study

Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01539291
Recruitment Status : Active, not recruiting
First Posted : February 27, 2012
Last Update Posted : October 27, 2017
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 2018
  Estimated Study Completion Date : June 2018